Catalyst

Slingshot members are tracking this event:

Phase 2 of Cellectar Bio's (CLRB) CLR 131 in Waldenstrom’s Macroglobulinemia data to be presented at ASCO June 4, 2021

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CLRB Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Clr 131